Evidence map›Paper›PMID 34774012›Full record

ReviewBMC public health2021

Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here.

Daniel T Halperin, Norman Hearst, Stephen Hodgins, Robert C Bailey, Jeffrey D Klausner, Helen Jackson, Richard G Wamai, Joseph A Ladapo, Mead Over, Stefan Baral and 2 more

Abstract readReview
In one paragraph

Review in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. An Examination of US COVID-19 Vaccine Distribution in New Jersey, Pennsylvania, and New York.International journal of environmental research and public health · 2022
    Article
  12. Journal editors and academic medicine.Croatian medical journal · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Response of Saudi Population to Strict Preventive Measures against COVID-19.International journal of environmental research and public health · 2021
    Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniel T HalperinGillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.ORCID 0000-0003-1557-5379
Norman HearstDepartment of Family and Community Medicine, School of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0003-1218-9173
Stephen HodginsSchool of Public Health, University of Alberta, Edmonton, AB, Canada.ORCID 0000-0001-8365-3311
Robert C BaileySchool of Public Health, University of Illinois, Chicago, IL, USA.ORCID 0000-0002-9202-1794
Jeffrey D KlausnerKeck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0002-6922-7364
Helen JacksonIndependent Consultant, Harare, Zimbabwe.
Richard G WamaiIntegrated Initiative for Global Health, Northeastern University, Boston, MA, USA.ORCID 0000-0001-6566-5159
Joseph A LadapoDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.ORCID 0000-0002-8518-4800
Mead OverCenter for Global Development, Washington, D.C, USA.
Stefan BaralDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-5482-2419
Kevin Escandón *School of Medicine, Universidad del Valle, Cali, Colombia. kevin.escandonvargas@gmail.com.ORCID 0000-0002-7173-7486
Monica Gandhi *Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0002-7025-1994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStrategies to control coronavirus 2019 disease (COVID-19) have often been based on preliminary and limited data and have tended to be slow to evolve as new evidence emerges. Yet knowledge about COVID-19 has grown exponentially, and the expanding rollout of vaccines presents further opportunity to reassess the response to the pandemic more broadly. MAIN TEXT: We review the latest evidence concerning 10 key COVID-19 policy and strategic areas, specifically addressing: 1) the expansion of equitable vaccine distribution, 2) the need to ease restrictions as hospitalization and mortality rates eventually fall, 3) the advantages of emphasizing educational and harm reduction approaches over coercive and punitive measures, 4) the need to encourage outdoor activities, 5) the imperative to reopen schools, 6) the far-reaching and long-term economic and psychosocial consequences of sustained lockdowns, 7) the excessive focus on surface disinfection and other ineffective measures, 8) the importance of reassessing testing policies and practices, 9) the need for increasing access to outpatient therapies and prophylactics, and 10) the necessity to better prepare for future pandemics.

conclusionsWhile remarkably effective vaccines have engendered great hope, some widely held assumptions underlying current policy approaches call for an evidence-based reassessment. COVID-19 will require ongoing mitigation for the foreseeable future as it transforms from a pandemic into an endemic infection, but maintaining a constant state of emergency is not viable. A more realistic public health approach is to adjust current mitigation goals to be more data-driven and to minimize unintended harms associated with unfocused or ineffective control efforts. Based on the latest evidence, we therefore present recommendations for refining 10 key policy areas, and for applying lessons learned from COVID-19 to prevent and prepare for future pandemics.

Indexed as

COVID-19Communicable Disease ControlHumansPandemicsPolicySARS-CoV-2COVID-19Evidence-based recommendationsHarm reductionOutdoor transmissionPandemicPandemic preparednessPolicyPublic healthSARS-CoV-2School closureVaccines

Identifiers

PMID34774012
PMCPMC8590121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.